A Study Comparing Three Methods of Outpatient Follow up After Surgical Admission; Text Message, Phone Call and In-person Appointment (ISOTOPE)

April 22, 2021 updated by: Paul Cromwell, Connolly Hospital Blanchardstown

An Open Label Randomised Control Trial Comparing Three Methods of Outpatient Follow up After Surgical Admission in Connolly Hospital Blanchardstown; Text Message, Phone Call and In-person Appointment

This study compares three different methods of outpatient follow up after surgical admission to Connolly Hospital Blanchardstown. The three arms of the study are text message, telephone call or in-person outpatient follow up. Data will be collected to identify complications identified in each arm along with the rate of non-response to the follow up methods and the level of satisfaction with the method. Willingness to use a telemedicine app in the future will also be evaluated through satisfaction survey.

Study Overview

Detailed Description

This is a non-blinded, single centre open randomised control trial of the outpatient follow up method following surgical admission to Connolly Hospital Blanchardstown.

All eligible patients will be randomised into three arms, text message, telephone or in-person follow up. The follow up will be carried out at 6-8 weeks following discharge. The rate of complications, the non-response rate and the level of satisfaction will be compared between the three groups.

Willingness to use a telemedicine app in the future in place of an in-person follow up will also be measured by patient satisfaction questionnaire.

Study Type

Interventional

Enrollment (Actual)

208

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Co. Dublin
      • Dublin 15, Co. Dublin, Ireland, D07 A59E
        • Connolly Hospital Blanchardstown

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Surgical patients admitted either as an emergency or for an elective procedure
  • 16 years or older

Exclusion Criteria:

  • Did not consent or cannot give consent
  • Age less than 16
  • No smartphone
  • Further follow up required for treatment of further investigation
  • Diagnosis or suspected diagnosis of malignancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Text Message
Patients will be followed up with a series of text messages at 6-8 weeks
A text message will be sent to the patient 6-8 weeks following discharge
Active Comparator: Telephone
Patients will be followed with a telephone conversation at 6-8 weeks
The patient will be followed up at 6-8 weeks following discharge with a telephone call
Active Comparator: In person
Patients will be followed in person in the Outpatient department at 6-8 weeks
The patient will be followed up at 6-8 weeks following discharge in person in the outpatient department

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Complications that require further follow up
Time Frame: 6-8 weeks
Complications are identified by patient record and follow up method selected
6-8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Satisfaction in follow up
Time Frame: 8-10 weeks
A questionnaire will assess how happy based on a survey patients were with their follow up method. The CSQ 8 score will be used along with a previously published questionnaire from this institiution. In the CSQ-8 questionnaire a higher score indicates more satisfaction.
8-10 weeks
Willingness to use a virtual clinic app in the future
Time Frame: 8-10 weeks
A questionnaire will assess patients preference in further follow up, specifically are patients happy to use a telemedicine based app. (answer no definitely not, no not really, yes generally, yes definitely.
8-10 weeks
Follow up preference
Time Frame: 8-10 weeks
Preferred follow up method will be identified by above patient questionnaire (text, phone or OPD)
8-10 weeks
Lost to follow up
Time Frame: 6-8 weeks
number of patients that are lost to follow up per follow up method
6-8 weeks
Further procedures arranged
Time Frame: 8-10 weeks
number of patients who have an additional procedure arranged which will be identified in the medical record
8-10 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Paul M Cromwell, BM BS BA MRCS, Department of Surgery, Connolly Hospital Blanchardstown, Dublin 15
  • Study Chair: Thomas N Walsh, MD MCh FRCSI, Department of Surgery, Connolly Hospital Blanchardstown, Dublin 15

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 16, 2019

Primary Completion (Actual)

June 21, 2020

Study Completion (Actual)

June 21, 2020

Study Registration Dates

First Submitted

September 15, 2019

First Submitted That Met QC Criteria

January 27, 2020

First Posted (Actual)

January 28, 2020

Study Record Updates

Last Update Posted (Actual)

April 26, 2021

Last Update Submitted That Met QC Criteria

April 22, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

IPD Plan Description

All data will be shared with other researchers if requested

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on General Surgery

Clinical Trials on Text message follow up

Subscribe